COMP <GO>
CNC vs JNJ // 10Y YIELD & FRED MACRO BETA
Centene Corporation (NYSE) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: CNC 2
— JNJ 10
▲ 10Y YIELD & FRED MACRO BETA LEADER: JNJ
LAST: $68.62 (+2.34%) • MKT CAP: $33.97B
macro-sensitivity
0.94
LAST: $275.20 (+1.54%) • MKT CAP: $662.49B
macro-sensitivity
1.08
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CNC VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CNC | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 8.10% | 67.90% | -59.80 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -31.00% | 25.50% | -56.50 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 18.5x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 12.72% | 2.97% | +9.75 | CNC | /fcf-yield <GO> |
| Operating Margin | -4.40% | 34.70% | -39.10 | JNJ | /operating-margins <GO> |
| Net Profit Margin | -3.80% | 28.50% | -32.30 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 20.00% | 6.00% | +14.00 | CNC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.52 | 5.59 | -3.07 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | JNJ | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 53.9 | 62.1 | -8.20 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | 0.94 | 1.08 | -0.14 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 36.0x | 23.0x | +13.00 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $33.97B | $662.49B | -$628.52B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CNC REV | JNJ REV | CNC GROSS % | JNJ GROSS % | CNC FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $174.58B | $94.19B | 8.1% | 67.9% | $4.32B | $19.70B |
| FY 2024 | $145.50B | $88.82B | 11.7% | 69.1% | -$490.0M | $19.84B |
| FY 2023 | $140.09B | $85.16B | — | — | $1.75B | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CNC // BETA 0.94
JNJ // BETA 1.08